Leukemia Research
Volume 34, Issue 10 , Pages 1302-1307, October 2010

FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657

  • Bianca F. Goemans

      Affiliations

    • Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Pediatric Hematology and Oncology, VU University Medical Center, POB 7057, 1007 MB Amsterdam, The Netherlands. Tel.: +31 20 4442420; fax: +31 20 4442422.
  • ,
  • Christian M. Zwaan

      Affiliations

    • Pediatric Oncology and Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
  • ,
  • Jacqueline Cloos

      Affiliations

    • Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Desiree de Lange

      Affiliations

    • Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Anne H. Loonen

      Affiliations

    • Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Dirk Reinhardt

      Affiliations

    • AML-BFM Study Group, Hannover Medical School, Hannover, Germany
  • ,
  • Karel Hählen

      Affiliations

    • Pediatric Oncology and Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    • DCOG, The Hague, The Netherlands
  • ,
  • Brenda E.S. Gibson

      Affiliations

    • UK Childhood Leukaemia Working Party, United Kingdom
  • ,
  • Ursula Creutzig

      Affiliations

    • AML-BFM Study Group, Hannover Medical School, Hannover, Germany
  • ,
  • Gertjan J.L. Kaspers

      Affiliations

    • Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands

Received 4 November 2009; received in revised form 20 March 2010; accepted 8 April 2010. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(10)00206-7

doi:10.1016/j.leukres.2010.04.004

Leukemia Research
Volume 34, Issue 10 , Pages 1302-1307, October 2010